Study Examines Sleep Impairments and Mental Health in COVID-19 Patients

Impact of COVID-19 on Mental Health

The COVID-19 pandemic has profoundly affected individuals and communities worldwide, notably in mental health. Recent research indicates a marked increase in anxiety disorders and depression since the pandemic began. Additionally, studies have explored potential links between adverse mental health outcomes and acute COVID-19 infections.

Sleep Problems Associated with COVID-19

Emerging evidence suggests a correlation between COVID-19 and sleep disturbances. A meta-analysis revealed that sleep disorders were reported by 74.8% of COVID-19 patients, compared to 36.0% among healthcare workers and 32.3% in the general population. While further investigation is necessary to understand these relationships, it is acknowledged that sleep quality may influence mental health outcomes.

Study Objectives and Methodology

Researchers aimed to explore the prevalence of anxiety and depressive disorders alongside sleep impairments in hospitalized COVID-19 patients. They also sought to document patients’ experiences to better understand these phenomena. Findings from this study were published in the journal *Neuroscience and Behavioral Physiology*.

Eligible participants completed anonymous electronic questionnaires that included three diagnostic assessments: the Hospital Anxiety and Depression Scale (HADS-A and HADS-D) for anxiety and depression, the Multidimensional Fatigue Inventory (MFI-20), and the Pittsburgh Sleep Quality Index (PSQI). The HADS tools are widely used to evaluate anxiety and depression in hospital settings, while the MFI-20 assesses fatigue based on self-reported symptoms. The PSQI evaluates sleep health across seven different metrics related to sleep duration, disturbances, and overall quality.

Participants also engaged in virtual interviews to share their experiences with the researchers.

Key Findings

Among the 119 patients surveyed, 13 exhibited elevated HADS-A scores, five had elevated HADS-D scores, and 15 displayed elevated scores on both measures. A total of 87 patients reported increased fatigue as indicated by the MFI-20, while 32 showed symptoms of sleep disorders according to the PSQI.

Patients with higher HADS-A scores reported intrusive hypochondriac thoughts, with eight experiencing sleep disturbances characterized by prolonged time to fall asleep. Additionally, five of these patients faced daytime fatigue and concentration difficulties. Those with elevated HADS-D scores typically experienced low mood and hopelessness, with four also suffering from daytime fatigue.

In the subset of 15 patients with elevated scores on both HADS metrics, eight reported trouble falling asleep, and ten experienced daytime fatigue, often associated with COVID-19-related anxiety. Notably, while fatigue was prevalent among patients with elevated HADS scores, 45% of those without such scores also reported fatigue, suggesting it may be indicative of COVID-19 itself rather than solely linked to anxiety or depression.

Conclusion and Future Research Directions

The study indicates that depressive and anxious symptoms, along with sleep disturbances, were common among the hospitalized COVID-19 patients surveyed. However, due to the limited sample size, further research is essential to determine whether these findings are consistent across a larger and more diverse group of COVID-19 patients. Additional studies are also needed to clarify the relationship between COVID-19, sleep disturbances, and mental health, as well as to identify effective interventions for addressing potential risks.